We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Syrris Announces Exclusive Agreement to Offer Advanced Crystallization Control and Particle Engineering

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Syrris, has announced that it has signed an exclusive worldwide agreement with Prosonix, a world leader in patented sonocrystallization technology. By combining Prosonix’s ultrasound technology with Syrris’s Atlas jacketed reactor platform, the Atlas SonoLab SL10 sonocrystalizer enables the reproducible control of crystallizations and allows selectivity of parameters such as particle size, shape, crystallinity and polymorph.

Mike Hawes, CEO of Syrris commented, “This is excellent news for Syrris’ customers and therefore Syrris. The Atlas SonoLab SL10 system offers unrivalled crystallization control, enabling narrower particle size distribution, higher purity samples and greater polymorph selectivity than traditional techniques.”

The Atlas SonoLab System is a high-performance, automated ultrasound system for sonocrystallization and sonomilling. With advanced control of nucleation and growth rate, the Atlas SonoLab System is ideal for particle engineering.

Furthermore, utilising the new SonoLab equipment in conjunction with the Atlas platform provides a basis for quality ultrasonic experiments and a seamless transition from laboratory to pilot plant at scales ranging from 100 ml to 100 L.